Stock listing

Resmed Inc.

Selected listing: 895878 · LSX · EUR · DE

Resmed Inc. (LS Exchange: 895878), Health Technology. Latest release Oct 1, 2026: Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026.

895878:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: 895878
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LS Exchange
Currency: EUR

About Resmed Inc.

Resmed Inc. (Ticker: RMD) is a public company operating in the American market, specializing in innovative solutions for sleep and respiratory disorders. The company focuses on providing high-quality devices and cloud-connected solutions to enhance the management of chronic obstructive pulmonary disease and sleep apnea.

Latest news from Resmed Inc.

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

October 1, 2026

Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer

September 1, 2026

Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference

August 27, 2026

Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor

August 17, 2026

ResMed: Fiscal Q4 Earnings Snapshot

August 6, 2026

All Resmed Inc. news →

Events

Replays

ResMed Inc. (RMD) Q4 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
ResMed Inc. (RMD) Q3 2026 Earnings Call
Thu, Apr 30, 2026 · 04:30 PM ET
Watch
ResMed Inc. (RMD) Q2 2026 Earnings Call
Thu, Jan 29, 2026 · 04:30 PM ET
Watch

Research Resmed Inc.

Resmed Inc. company profile

View the public company page for Resmed Inc. on 6ix.

Resmed Inc. news

Read company news and market updates connected to Resmed Inc..

Resmed Inc. investor events

Find investor webinars, events, and replay context for Resmed Inc..